Immune-endocrine network in diabetes-tuberculosis nexus: does latent tuberculosis infection confer protection against meta-inflammation and insulin resistance?

Tuberculosis patients with diabetes, have higher sputum bacillary load, delayed sputum conversion, higher rates of drug resistance, higher lung cavitary involvement and extra-pulmonary TB infection, which is called as “Diabetes-Tuberculosis Nexus”. However, recently we have shown a reciprocal relati...

Full description

Bibliographic Details
Main Authors: Vivekanandhan Aravindhan, Srinivasan Yuvaraj
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-01-01
Series:Frontiers in Endocrinology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fendo.2024.1303338/full
_version_ 1797347456585826304
author Vivekanandhan Aravindhan
Srinivasan Yuvaraj
author_facet Vivekanandhan Aravindhan
Srinivasan Yuvaraj
author_sort Vivekanandhan Aravindhan
collection DOAJ
description Tuberculosis patients with diabetes, have higher sputum bacillary load, delayed sputum conversion, higher rates of drug resistance, higher lung cavitary involvement and extra-pulmonary TB infection, which is called as “Diabetes-Tuberculosis Nexus”. However, recently we have shown a reciprocal relationship between latent tuberculosis infection and insulin resistance, which has not been reported before. In this review, we would first discuss about the immune-endocrine network, which operates during pre-diabetes and incipient diabetes and how it confers protection against LTBI. The ability of IR to augment anti-TB immunity and the immunomodulatory effect of LTBI to quench IR were discussed, under IR-LTB antagonism. The ability of diabetes to impair anti-TB immunity and ability of active TB to worsen glycemic control, were discussed under “Diabetes-Tuberculosis Synergy”. The concept of “Fighter Genes” and how they confer protection against TB but susceptibility to IR was elaborated. Finally, we conclude with an evolutionary perspective about how IR and LTBI co-evolved in endemic zones, and have explained the molecular basis of “IR-LTB” Antagonism” and “DM-TB Synergy”, from an evolutionary perspective.
first_indexed 2024-03-08T11:48:02Z
format Article
id doaj.art-02cf0b4760904e34957e7aeddcb6221f
institution Directory Open Access Journal
issn 1664-2392
language English
last_indexed 2024-03-08T11:48:02Z
publishDate 2024-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Endocrinology
spelling doaj.art-02cf0b4760904e34957e7aeddcb6221f2024-01-24T14:37:26ZengFrontiers Media S.A.Frontiers in Endocrinology1664-23922024-01-011510.3389/fendo.2024.13033381303338Immune-endocrine network in diabetes-tuberculosis nexus: does latent tuberculosis infection confer protection against meta-inflammation and insulin resistance?Vivekanandhan AravindhanSrinivasan YuvarajTuberculosis patients with diabetes, have higher sputum bacillary load, delayed sputum conversion, higher rates of drug resistance, higher lung cavitary involvement and extra-pulmonary TB infection, which is called as “Diabetes-Tuberculosis Nexus”. However, recently we have shown a reciprocal relationship between latent tuberculosis infection and insulin resistance, which has not been reported before. In this review, we would first discuss about the immune-endocrine network, which operates during pre-diabetes and incipient diabetes and how it confers protection against LTBI. The ability of IR to augment anti-TB immunity and the immunomodulatory effect of LTBI to quench IR were discussed, under IR-LTB antagonism. The ability of diabetes to impair anti-TB immunity and ability of active TB to worsen glycemic control, were discussed under “Diabetes-Tuberculosis Synergy”. The concept of “Fighter Genes” and how they confer protection against TB but susceptibility to IR was elaborated. Finally, we conclude with an evolutionary perspective about how IR and LTBI co-evolved in endemic zones, and have explained the molecular basis of “IR-LTB” Antagonism” and “DM-TB Synergy”, from an evolutionary perspective.https://www.frontiersin.org/articles/10.3389/fendo.2024.1303338/fulllatent tuberculosisinsulin resistancediabetestuberculosiscytokineshormones
spellingShingle Vivekanandhan Aravindhan
Srinivasan Yuvaraj
Immune-endocrine network in diabetes-tuberculosis nexus: does latent tuberculosis infection confer protection against meta-inflammation and insulin resistance?
Frontiers in Endocrinology
latent tuberculosis
insulin resistance
diabetes
tuberculosis
cytokines
hormones
title Immune-endocrine network in diabetes-tuberculosis nexus: does latent tuberculosis infection confer protection against meta-inflammation and insulin resistance?
title_full Immune-endocrine network in diabetes-tuberculosis nexus: does latent tuberculosis infection confer protection against meta-inflammation and insulin resistance?
title_fullStr Immune-endocrine network in diabetes-tuberculosis nexus: does latent tuberculosis infection confer protection against meta-inflammation and insulin resistance?
title_full_unstemmed Immune-endocrine network in diabetes-tuberculosis nexus: does latent tuberculosis infection confer protection against meta-inflammation and insulin resistance?
title_short Immune-endocrine network in diabetes-tuberculosis nexus: does latent tuberculosis infection confer protection against meta-inflammation and insulin resistance?
title_sort immune endocrine network in diabetes tuberculosis nexus does latent tuberculosis infection confer protection against meta inflammation and insulin resistance
topic latent tuberculosis
insulin resistance
diabetes
tuberculosis
cytokines
hormones
url https://www.frontiersin.org/articles/10.3389/fendo.2024.1303338/full
work_keys_str_mv AT vivekanandhanaravindhan immuneendocrinenetworkindiabetestuberculosisnexusdoeslatenttuberculosisinfectionconferprotectionagainstmetainflammationandinsulinresistance
AT srinivasanyuvaraj immuneendocrinenetworkindiabetestuberculosisnexusdoeslatenttuberculosisinfectionconferprotectionagainstmetainflammationandinsulinresistance